Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 2-ARM PARALLEL-GROUP STUDY TO DETERMINE THE EFFICACY AND SAFETY OF CLONIDINE HYDROCHLORIDE TOPICAL GEL, 0.1% IN THE TREATMENT OF PAIN ASSOCIATED WITH PAINFUL DIABETIC NEUROPATHY

Next Previous
Search
Trial Profile

A MULTICENTER RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 2-ARM PARALLEL-GROUP STUDY TO DETERMINE THE EFFICACY AND SAFETY OF CLONIDINE HYDROCHLORIDE TOPICAL GEL, 0.1% IN THE TREATMENT OF PAIN ASSOCIATED WITH PAINFUL DIABETIC NEUROPATHY

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 28 Sep 2017

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Clonidine (Primary)
  • Indications Diabetic neuropathies; Neuropathic pain
  • Focus Registrational; Therapeutic Use
  • Acronyms RHAPSODY
  • Sponsors BioDelivery Sciences International

    • Most Recent Events

    • 17 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Mar 2015 Primary endpoint has not been met (change in average pain score over time), according to a BioDelivery Sciences International media release.
    • 16 Mar 2015 According to a BioDelivery Sciences International media release, if top-line results are positive, a regulatory submission is anticipated to occur in the EU during the second half of 2015.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top